實驗概要
The procedure presented below describes a method for collecting rat blood.
實驗步驟
Rat should be fully anesthetized (e.g., unresponsive to toe pinch).
1. Open Chest Method
1) Have ready a syringe (3–10 ml) containing ~0.3 ml air and with a 20 gauge needle attached.
2) Make an incision at the level of the xiphoid process and hold the xiphoid with a hemostat or forceps.
3) Beginning at the xiphoid, cut along the full length of the sternum just to the rat’s right of the midline, then make a lateral incision through the chest wall laterally to the rat’s left, just cranial to the diaphragm. Do this quickly, as there will be arterial bleeding from the chest wall incisions.
4) Continuing to hold the xiphoid, retract the chest wall flap laterally, and expose the heart with blunt dissection of the pleura and pericardium. If necessary, make a lateral incision to the right in the chest wall (there should be adequate exposure of the heart without the second lateral incision if the initial midline incision is slightly to the right of the sternum).
5) Insert the needle into the right ventricle and apply gentle negative pressure to the syringe to fill the syringe with blood. Excessive negative pressure will collapse the chamber. The right atrium also works well for drawing blood, but the left side of the heart is more difficult.
2. Closed Chest Method
1) Have ready a syringe (3–10 ml) containing ~0.3 ml air and with a 20 gauge needle attached.
2) Make an incision in the skin and abdominal wall, caudal to the sternum.
3) Using a hemostat or thumb forceps applied to the xiphoid process, retract the sternum cranially until the apex of the heart is visible against the diaphragm.
4) Insert the needle through the diaphragm and into the heart, applying gentle negative pressure once the heart has been punctured, and reposition the needle as necessary until blood flows into the syringe. Avoid excessive negative pressure, as it will collapse the heart chamber onto the needle tip.
研究闡明了SETD2在調控骨髓增生異常綜合征(MDS)向急性髓系白血病(AML)轉化過程中的作用機制,為MDS臨床治療提供了理論基礎和潛在靶標。MDS是最常見的髓系惡性腫瘤之一,是起源于造血干細胞的一......
為什么有些癌癥治療之后仍會復發?有時候,癌癥的相關治療可以有效地將癌細胞消除到無法檢測的水平,但是,如果停止治療,癌癥可能會復發。例如,在用酪氨酸激酶抑制劑藥物治療慢性粒細胞白血病患者是就會出現停藥后......
化療已使最常見的兒童期癌癥---急性淋巴細胞白血病(ALL)---成為最可治愈的癌癥之一,但是科學家們有證據表明這種治療也可能使某些患者復發。在一項新的研究中,來自中國和美國的研究人員報道由治療引起的......
在一項新的研究中,來自美國俄亥俄州大學的DaniloPerrotti和同事證實一種叫做FTY720的藥物能夠抑制由癌癥蛋白BCR-ABL導致的白血病小鼠模型的病情。由于這種藥物還能夠誘導從白血病患者獲......
來自中山大學有害生物控制與資源利用國家重點實驗室(StateKeyLaboratoryofBiocontrol,原生物防治國家重點實驗室),基因工程教育部重點實驗室(KeyLaboratoryofGe......